UBS Group AG - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 263 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$303,168
-80.3%
89,167
-57.4%
0.00%
-100.0%
Q2 2023$1,540,200
-39.2%
209,551
-14.3%
0.00%0.0%
Q1 2023$2,533,828
+3.2%
244,578
+17.6%
0.00%0.0%
Q4 2022$2,456,149
+34.9%
207,972
+139.6%
0.00%0.0%
Q3 2022$1,821,000
-17.5%
86,782
+22.0%
0.00%0.0%
Q2 2022$2,208,000
-25.2%
71,140
-1.0%
0.00%0.0%
Q1 2022$2,951,000
-56.8%
71,863
-54.2%
0.00%
-50.0%
Q4 2021$6,824,000
+56.1%
156,994
+79.8%
0.00%
+100.0%
Q3 2021$4,371,000
+125.1%
87,300
+183.1%
0.00%0.0%
Q2 2021$1,942,000
-62.0%
30,832
-44.0%
0.00%
-50.0%
Q1 2021$5,113,000
+66.7%
55,026
+60.7%
0.00%
+100.0%
Q4 2020$3,067,000
-47.5%
34,233
-39.5%
0.00%
-50.0%
Q3 2020$5,844,000
+8.6%
56,565
-16.8%
0.00%0.0%
Q2 2020$5,379,000
+556.0%
68,014
+379.5%
0.00%
Q1 2020$820,000
-74.6%
14,185
-76.3%
0.00%
-100.0%
Q4 2019$3,227,000
-45.7%
59,833
-47.3%
0.00%
-50.0%
Q3 2019$5,938,000
+347.1%
113,577
+313.4%
0.00%
+100.0%
Q2 2019$1,328,000
-35.9%
27,472
-33.0%
0.00%0.0%
Q1 2019$2,071,000
-58.8%
40,996
-51.7%
0.00%
-50.0%
Q4 2018$5,028,000
+95.8%
84,812
+117.4%
0.00%
+100.0%
Q3 2018$2,568,000
+89.4%
39,010
+45.3%
0.00%0.0%
Q2 2018$1,356,000
-67.8%
26,857
-66.4%
0.00%
-50.0%
Q1 2018$4,213,000
+222.3%
80,021
+184.5%
0.00%
+100.0%
Q4 2017$1,307,000
+11.6%
28,126
-2.8%
0.00%0.0%
Q3 2017$1,171,000
+87.1%
28,931
+57.0%
0.00%
Q2 2017$626,000
-36.0%
18,428
-45.3%
0.00%
-100.0%
Q1 2017$978,000
-17.5%
33,673
-6.6%
0.00%0.0%
Q4 2016$1,185,000
+57.2%
36,058
+50.8%
0.00%
Q3 2016$754,000
-9.9%
23,912
-19.7%
0.00%
-100.0%
Q2 2016$837,000
+70.1%
29,773
+120.2%
0.00%
Q1 2016$492,000
-17.3%
13,519
-9.0%
0.00%
Q4 2015$595,000
+119.6%
14,861
+56.3%
0.00%
Q3 2015$271,000
-42.3%
9,507
-33.4%
0.00%
Q2 2015$470,000
+167.0%
14,270
+133.1%
0.00%
Q1 2015$176,000
+780.0%
6,122
+729.5%
0.00%
Q4 2014$20,0007380.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders